Mar 15, 2021Potential TreatmentsFDA grants orphan drug designation for RP treatmentThe FDA has granted orphan drug designation for chemically induced photoreceptor-like cells to treat retinitis pigmentosa.
Mar 12, 2021LCALCA, early-onset severe retinal dystrophy: current management and clinical trialsRPE65-related LCA pivotal trials, . . . have paved the way for a new era of genetic treatments in ophthalmology.
Mar 7, 2021CRISPRGenome Editing in Retinal Diseases using CRISPR TechnologyBy: Glenn Yiu, MD, PhD - Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, California Ophthalmology
Jan 31, 2021RHOClinical Characteristics and Natural History of RHO-Associated RPA multi-center, chart review of 100 patients with RHO-associated adRP. Based on central visual fields, the optimal window of intervention is